Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome.
Nakai R, Varnum S, Field RL, Shi H, Giwa R, Jia W, Krysa SJ, Cohen EF, Borcherding N, Saneto RP, Tsai RC, Suganuma M, Ohta H, Yokota T, Brestoff JR.
Nakai R, et al. Among authors: saneto rp.
Nat Metab. 2024 Oct;6(10):1886-1896. doi: 10.1038/s42255-024-01125-5. Epub 2024 Sep 2.
Nat Metab. 2024.
PMID: 39223312